Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.220
-0.040 (-1.23%)
At close: May 26, 2026, 4:00 PM EDT
3.160
-0.060 (-1.86%)
After-hours: May 26, 2026, 7:47 PM EDT

TriSalus Life Sciences Revenue

TriSalus Life Sciences had revenue of $8.90M in the quarter ending March 31, 2026, a decrease of -2.92%. This brings the company's revenue in the last twelve months to $44.88M, up 39.64% year-over-year. In the year 2025, TriSalus Life Sciences had annual revenue of $45.15M with 53.41% growth.

Revenue (ttm)
$44.88M
Revenue Growth
+39.64%
P/S Ratio
4.41
Revenue / Employee
$440,029
Employees
102
Market Cap
197.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202545.15M15.72M53.41%
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen351.50M
Treace Medical Concepts207.32M
InfuSystem Holdings142.40M
RxSight127.48M
Owlet107.06M
CVRx, Inc.59.07M
Apyx Medical55.90M
Profound Medical18.81M
Revenue Rankings

TLSI News

More News